F. F. de Campos, “LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER”, MAST, vol. 29, nº 3, p. 14, set. 2019.